3,464 results on '"Galetta, Steven"'
Search Results
2. MOG Antibody–Associated Disease and Thymic Hyperplasia
3. RENEWED: A follow-up study of the opicinumab phase 2 RENEW study in participants with acute optic neuritis
4. Optical Coherence Tomography for Neuro-Ophthalmology
5. Characteristics associated with 30-day post-stroke readmission within an academic urban hospital network
6. Vision as a piece of the head trauma puzzle
7. Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing–Remitting Multiple Sclerosis: STRIVE Data Analysis
8. Optical coherence tomography angiography measurements in multiple sclerosis: a systematic review and meta-analysis
9. Artificial intelligence extension of the OSCAR‐IB criteria
10. Correction to: Improvements in Cognitive Processing Speed, Disability, and Patient‑Reported Outcomes in Patients with Early Relapsing‑Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4‑year, Real‑World, Open‑Label Study
11. Tele-Neuro-Ophthalmology During the Age of COVID-19.
12. Longitudinal stability of inter-eye differences in optical coherence tomography measures for identifying unilateral optic nerve lesions in multiple sclerosis
13. Two cases of unilateral cone–rod dysfunction presenting in adult females
14. Neurology faculty comfort and experience with communication skills
15. Trends in concussion mechanism of injury during the COVID-19 pandemic
16. Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment
17. Improvements in Cognitive Processing Speed, Disability, and Patient-Reported Outcomes in Patients with Early Relapsing-Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4-year, Real-World, Open-Label Study
18. Life stressors significantly impact long-term outcomes and post-acute symptoms 12-months after COVID-19 hospitalization
19. MICK (Mobile Integrated Cognitive Kit) app: Feasibility of an accessible tablet-based rapid picture and number naming task for concussion assessment in a division 1 college football cohort
20. Accuracy of clinical versus oculographic detection of pathological saccadic slowing
21. Demographic and social determinants of cognitive dysfunction following hospitalization for COVID-19
22. Early Neurorehabilitation and Recovery from Disorders of Consciousness After Severe COVID-19
23. A young man in “double-trouble”: Hallucinations and cranial nerve palsies: From the National Multiple Sclerosis Society Case Conference Proceedings
24. Toxic Metabolic Encephalopathy in Hospitalized Patients with COVID-19
25. Long-term outcomes in patients presenting with optic neuritis: Analyses of the MSBase registry
26. Normative Data and Conversion Equation for Spectral-Domain Optical Coherence Tomography in an International Healthy Control Cohort
27. Cerebrospinal fluid from COVID-19 patients with olfactory/gustatory dysfunction: A review
28. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications
29. Cerebrospinal fluid findings in patients with seizure in the setting of COVID-19: A review of the literature
30. MICK (Mobile Integrated Cognitive Kit) App for Concussion Assessment in a Youth Ice Hockey League.
31. Neuro-Ophthalmic Manifestations of Adult Polyglucosan Body Disease.
32. Increase in Ventricle Size and the Evolution of White Matter Changes on Serial Imaging in Critically Ill Patients with COVID-19
33. Multiple Sclerosis Followed by Neuromyelitis Optica Spectrum Disorder: From the National Multiple Sclerosis Society Case Conference Proceedings
34. Recurrent Optic Neuritis and Perineuritis Followed by an Unexpected Discovery: From the National Multiple Sclerosis Society Case Conference Proceedings
35. Editorsʼ Note: Normobaric Hyperoxia Combined With Endovascular Treatment for Patients With Acute Ischemic Stroke: A Randomized Controlled Clinical Trial
36. Cerebrospinal fluid in COVID-19: A systematic review of the literature
37. Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study
38. AI in Neuro-Ophthalmology: Current Practice and Future Opportunities.
39. Hereditary Optic Neuropathies: An Updated Review.
40. Role for OCT in detecting hemi-macular ganglion cell layer thinning in patients with multiple sclerosis and related demyelinating diseases
41. The psychosocial implications of COVID-19 for a neurology program in a pandemic epicenter
42. The SUN test of vision: Investigation in healthy volunteers and comparison to the mobile universal lexicon evaluation system (MULES)
43. Hemorrhagic stroke and anticoagulation in COVID-19
44. COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome
45. Rapid picture naming in Parkinson's disease using the Mobile Universal Lexicon Evaluation System (MULES)
46. Periodic Alternating Gaze Deviation
47. Editors' Note: What Is the Ideal Brain Criterion of Death? Nonclinical Considerations: The UDDA Revision Series
48. Editors' Note: Age-Related Changes in Neurologic Examination and Sensory Nerve Amplitude in the General Population
49. Distinguishing Between Myelin Oligodendrocyte Glycoprotein Disease Optic Neuritis and Nonarteritic Anterior Ischemic Optic Neuropathy
50. Binocular Visual Function Testing in an Alzheimer’s Disease Research Center (ADRC) Cohort: Low-contrast Letter Acuity and Rapid Automatized Naming (RAN) Tasks of MULES and SUN (S40.006)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.